Flora Peyvandi to Male
This is a "connection" page, showing publications Flora Peyvandi has written about Male.
Connection Strength
0.211
-
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study. Thromb Haemost. 2021 Aug; 121(8):1087-1096.
Score: 0.013
-
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19. Intern Emerg Med. 2021 08; 16(5):1223-1229.
Score: 0.012
-
The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost. 2021 02; 19(2):513-521.
Score: 0.012
-
Complement activation and endothelial perturbation parallel COVID-19 severity and activity. J Autoimmun. 2021 01; 116:102560.
Score: 0.012
-
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report. Am J Gastroenterol. 2020 07 01; 115(7):1140-1142.
Score: 0.012
-
Complement activation in patients with COVID-19: A novel therapeutic target. J Allergy Clin Immunol. 2020 Jul; 146(1):215-217.
Score: 0.012
-
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 2020 07; 105(7):1957-1962.
Score: 0.011
-
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A. Haemophilia. 2019 May; 25(3):521-526.
Score: 0.011
-
Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series. J Thromb Haemost. 2019 03; 17(3):492-498.
Score: 0.011
-
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome. Semin Thromb Hemost. 2019 Feb; 45(1):36-42.
Score: 0.010
-
Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis. Thromb Res. 2018 09; 169:76-81.
Score: 0.010
-
Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. Transfusion. 2018 02; 58(2):413-422.
Score: 0.010
-
Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura. J Thromb Thrombolysis. 2012 Oct; 34(3):416-8.
Score: 0.007
-
Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura. Blood Transfus. 2013 Apr; 11(2):241-4.
Score: 0.007
-
Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol. 2002 Jun; 117(3):685-92.
Score: 0.003
-
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy. Microbiol Spectr. 2021 10 31; 9(2):e0054921.
Score: 0.003
-
Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiol Med. 2021 May; 126(5):722-728.
Score: 0.003
-
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19. J Autoimmun. 2021 02; 117:102595.
Score: 0.003
-
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. J Allergy Clin Immunol. 2021 Feb; 147(2):561-566.e4.
Score: 0.003
-
Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultrasound? J Ultrasound. 2021 Jun; 24(2):165-173.
Score: 0.003
-
Romeo and Juliet: Revisited (at the time of COVID-19). Eur J Intern Med. 2020 11; 81:94.
Score: 0.003
-
Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
Score: 0.003
-
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register. Intern Emerg Med. 2019 11; 14(8):1347-1352.
Score: 0.003
-
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia. 2019 Jan; 25(1):33-44.
Score: 0.003
-
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls. Haemophilia. 2018 Sep; 24(5):726-732.
Score: 0.003
-
An unusual diagnosis in a 31-year-old man with abdominal pain and hyponatremia. Intern Emerg Med. 2018 Dec; 13(8):1233-1238.
Score: 0.003
-
Persistent and severe hypoglycemia associated with trimethoprim-sulfamethoxazole in a frail diabetic man on polypharmacy: A case report and literature review?. Int J Clin Pharmacol Ther. 2018 Feb; 56(2):86-89.
Score: 0.003
-
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia. Br J Haematol. 2018 12; 183(5):825-828.
Score: 0.003
-
Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis. Clin Appl Thromb Hemost. 2018 Jul; 24(5):808-814.
Score: 0.003
-
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis. Blood. 2017 10 12; 130(15):1757-1759.
Score: 0.002
-
Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood. 2017 07 27; 130(4):e1-e6.
Score: 0.002
-
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis. Blood Transfus. 2018 02; 16(2):215-220.
Score: 0.002
-
Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis. Liver Int. 2017 09; 37(9):1295-1303.
Score: 0.002
-
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A. Blood. 2017 03 09; 129(10):1245-1250.
Score: 0.002
-
Frequency of the p.Gly262Asp mutation in congenital Factor X deficiency. Eur J Clin Invest. 2015 Oct; 45(10):1087-91.
Score: 0.002
-
Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago. Blood. 2006 Jun 15; 107(12):4666-8.
Score: 0.001